Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Sartorius AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Sartorius AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Sartorius AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Sartorius AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Sartorius AG, Medical Devices Deals, 2012 to YTD 2018 10
Sartorius AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Sartorius AG, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
ViroCyt Raises USD4 Million in Venture Financing 12
ViroCyt Raises USD3.5 Million in Venture Financing 13
IntelliCyt Raises USD0.05 Million in Venture Financing 14
ViroCyt Raises US$3.5 Million In Series A Financing 15
ViroCyt Raises US$2.6 Million In Series B Financing 16
Private Equity 17
SFW Capital Partners Invests In Essen BioScience 17
Partnerships 18
Quad Technologies Enters into Partnership with Sartorius Stedim Biotech 18
IntelliCyt Partners with SpectraGenetics 19
Genedata Enters into Integration Agreement with IntelliCyt 20
Sartorius Stedim Biotech Enters Into Co-Development Agreement With BD Diagnostic 21
ProMetic Life Sciences Enters Into Co-Marketing Agreement With Sartorius Stedim Biotech 22
Sartorius Stedim Biotech Enters Into Agreement With c-LEcta 23
Sartorius Stedim Biotech Enters Into Co-Development With Refine Technology 24
Acquisition 25
Sartorius Acquires Essen BioScience for USD320 Million 25
Sartorius Stedim Biotech Acquires Cellca 26
Sartorius Stedim Biotech Acquires BioOutsource 27
Sartorius Stedim Biotech Acquires TAP Biosystems for USD44.7 Million 28
Sartorius AG – Key Competitors 29
Sartorius AG – Key Employees 30
Sartorius AG – Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Recent Developments 34
Financial Announcements 34
Jul 24, 2018: Business Figures for the First Half of 2018: Sartorius Records Double-Digit Sales Growth 34
Apr 24, 2018: First-Quarter Figures: Sartorius Starts off Fiscal 2018 Successfully 36
Jan 31, 2018: Sartorius grows significantly again in sales revenue and earnings in 2017 – positive outlook for 2018 38
Oct 25, 2017: Nine-Month Figures for 2017: Sartorius Continues to Grow Profitably in a Challenging Environment 40
Jul 21, 2017: Business Figures for the First Half of 2017: Sartorius Continues to Grow 42
Jul 21, 2017: Solid growth at Sartorius Stedim Biotech; profits continue to rise 44
Apr 24, 2017: First-quarter figures: Sartorius starts off 2017 with double-digit growth 45
Feb 23, 2017: Sartorius Reviews Fiscal 2016 46
Jan 30, 2017: Sartorius Grows by Double Digits in Sales Revenue and Earnings in 2016 – Positive Outlook for 2017 48
Corporate Communications 50
Feb 21, 2017: Resolutions of the Sartorius Supervisory Board 50
Government and Public Interest 51
Nov 29, 2017: Second Sartorius Research Xchange Forum Focuses on Regenerative Medicine and Cell Therapy 51
Other Significant Developments 52
Oct 02, 2018: Genedata Bioprocess Offers Out-of-the-Box Integration with ambr Bioreactors 52
Oct 16, 2017: Sartorius Group: Key Figures on 9-Month Business Development in 2017 53
May 04, 2017: Sartorius Stedim Biotech Launches Chemistry Testing Services 54
Appendix 55
Methodology 55
About GlobalData 55
Contact Us 55
Disclaimer 55
Sartorius AG, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Sartorius AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Sartorius AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Sartorius AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Sartorius AG, Deals By Therapy Area, 2012 to YTD 2018 9
Sartorius AG, Medical Devices Deals, 2012 to YTD 2018 10
Sartorius AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
ViroCyt Raises USD4 Million in Venture Financing 12
ViroCyt Raises USD3.5 Million in Venture Financing 13
IntelliCyt Raises USD0.05 Million in Venture Financing 14
ViroCyt Raises US$3.5 Million In Series A Financing 15
ViroCyt Raises US$2.6 Million In Series B Financing 16
SFW Capital Partners Invests In Essen BioScience 17
Quad Technologies Enters into Partnership with Sartorius Stedim Biotech 18
IntelliCyt Partners with SpectraGenetics 19
Genedata Enters into Integration Agreement with IntelliCyt 20
Sartorius Stedim Biotech Enters Into Co-Development Agreement With BD Diagnostic 21
ProMetic Life Sciences Enters Into Co-Marketing Agreement With Sartorius Stedim Biotech 22
Sartorius Stedim Biotech Enters Into Agreement With c-LEcta 23
Sartorius Stedim Biotech Enters Into Co-Development With Refine Technology 24
Sartorius Acquires Essen BioScience for USD320 Million 25
Sartorius Stedim Biotech Acquires Cellca 26
Sartorius Stedim Biotech Acquires BioOutsource 27
Sartorius Stedim Biotech Acquires TAP Biosystems for USD44.7 Million 28
Sartorius AG, Key Competitors 29
Sartorius AG, Key Employees 30
Sartorius AG, Other Locations 31
Sartorius AG, Subsidiaries 31
List of Figures
Sartorius AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sartorius AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sartorius AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sartorius AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sartorius AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Sartorius AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Sartorius AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Sartorius AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Sartorius AG, Medical Devices Deals, 2012 to YTD 2018 10